This Article Full Text Full Text (PDF) All Versions of this Article: 113/22/2598    most recent CIRCULATIONAHA.105.607127v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peng, L. F. Articles by Lock, J. E. Search for Related Content PubMed PubMed Citation Articles by Peng, L. F. Articles by Lock, J. E. Related Collections Catheter-based coronary and valvular interventions: other Pediatric and congenital heart disease, including cardiovascular surgery Related Articles

(Circulation. 2006;113:2598-2605.)
© 2006 American Heart Association, Inc.

Pediatric Cardiology

Endovascular Stenting of Obstructed Right Ventricle–to–Pulmonary Artery Conduits

A 15-Year Experience

Lynn F. Peng, MD; Doff B. McElhinney, MD; Alan W. Nugent, MD; Andrew J. Powell, MD; Audrey C. Marshall, MD; Emile A. Bacha, MD; James E. Lock, MD

From the Departments of Cardiology (L.F.P., D.B.M., A.W.N., A.J.P., A.C.M., J.E.L.) and Cardiac Surgery (E.A.B.), Children’s Hospital Boston; and Departments of Pediatrics (L.F.P., D.B.M., A.W.N., A.J.P., A.C.M., J.E.L.) and Surgery (E.A.B.), Harvard Medical School, Boston, Mass.

Correspondence to James E. Lock, MD, Department of Cardiology, Children’s Hospital Boston, 300 Longwood Ave, Boston, MA 02115. E-mail james.lock{at}cardio.chboston.org

Received October 14, 2005; de novo received December 8, 2005; revision received February 13, 2006; accepted March 13, 2006.

Background— The optimal treatment for dysfunctional right ventricle–to–pulmonary artery (RV-PA) conduits is unknown. Limited follow-up data on stenting of RV-PA conduits have been reported.

Methods and Results— Between 1990 and 2004, deployment of balloon-expandable bare stents was attempted in 242 obstructed RV-PA conduits in 221 patients (median age, 6.7 years). Acute hemodynamic changes after stenting included significantly decreased RV systolic pressure (89±18 to 65±20 mm Hg, P<0.001) and peak RV-PA gradient (59±19 to 27±14 mm Hg, P<0.001). There were no deaths, and, aside from 5 malpositioned stents requiring surgical removal, there were no serious procedural complications. During follow-up of 4.0±3.2 years, 9 patients died and 2 underwent heart transplantation, none related to catheterization or stent malfunction. During 155 follow-up catheterizations in 126 patients, the stent was redilated in 83 patients and additional stents were placed in 41. Stent fractures were diagnosed in 56 patients (43%) and associated with stent compression and substernal location but did not cause acute hemodynamic consequences. By Kaplan-Meier analysis, median freedom from conduit surgery after stenting was 2.7 years (3.9 years in patients >5 years), with younger age, homograft conduit, conduit diameter 10 mm, diagnosis other than tetralogy of Fallot, Genesis stent, higher prestent RV:aortic pressure ratio, and stent malposition associated with shorter freedom from surgery. Tricuspid regurgitation and RV function did not change between stent implantation and subsequent surgery.

Conclusions— Conduit stenting is an effective interim treatment for RV-PA conduit obstruction and prolongs conduit lifespan in most patients. Stent fractures were common but not associated with significant complications or earlier conduit reoperation.

---

 

CLINICAL PERSPECTIVE

Related Articles:

Issue Highlights
Circulation 2006 113: 2565. [Full Text]

Optimal Management Strategies for Patients With Complex Congenital Heart Disease

Rae-Ellen W. Kavey
Circulation 2006 113: 2569-2571. [Full Text]

This article has been cited by other articles:

				P. Lurz, L. Coats, S. Khambadkone, J. Nordmeyer, Y. Boudjemline, S. Schievano, V. Muthurangu, T. Y. Lee, G. Parenzan, G. Derrick, et al. Percutaneous Pulmonary Valve Implantation: Impact of Evolving Technology and Learning Curve on Clinical Outcome Circulation, April 15, 2008; 117(15): 1964 - 1972. [Abstract] [Full Text] [PDF]

				J. F. Rhodes, Z. M. Hijazi, and R. J. Sommer Pathophysiology of Congenital Heart Disease in the Adult, Part II: Simple Obstructive Lesions Circulation, March 4, 2008; 117(9): 1228 - 1237. [Full Text] [PDF]

				I. Inglessis and M. J. Landzberg Interventional Catheterization in Adult Congenital Heart Disease Circulation, March 27, 2007; 115(12): 1622 - 1633. [Full Text] [PDF]

				J. Nordmeyer, S. Khambadkone, L. Coats, S. Schievano, P. Lurz, G. Parenzan, A. M. Taylor, J. E. Lock, and P. Bonhoeffer Risk Stratification, Systematic Classification, and Anticipatory Management Strategies for Stent Fracture After Percutaneous Pulmonary Valve Implantation Circulation, March 20, 2007; 115(11): 1392 - 1397. [Abstract] [Full Text] [PDF]

				R.-E. W. Kavey Optimal Management Strategies for Patients With Complex Congenital Heart Disease Circulation, June 6, 2006; 113(22): 2569 - 2571. [Full Text] [PDF]